Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Best Peptides for Hot Flashes: Research-Backed Comparison

Thymalin Thymic immune regulation; modulates T-cell activity and suppresses inflammatory cytokines (IL-6, TNF-α) Observational study (St. Petersburg Institute). 30% cytokine reduction, 40–50% hot flash frequency reduction over 8 weeks in postmenopausal women 5

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Thymalin
  • Thymic immune regulation; modulates T-cell activity and suppresses inflammatory cytokines (IL-6, TNF-α)
  • Observational study (St. Petersburg Institute). 30% cytokine reduction, 40–50% hot flash frequency reduction over 8 weeks in postmenopausal women
  • 5–10 mg subcutaneously 2–3×/week
  • Subcutaneous injection
  • Most directly studied for vasomotor symptoms; immune modulation approach avoids estrogen receptor risks but lacks placebo-controlled RCTs
  • KPV
  • Inhibits NF-κB translocation; blocks inflammatory gene transcription; crosses blood-brain barrier
  • Preclinical models show 50–70% reduction in IL-6/TNF-α; no direct human trials for menopause-related symptoms
  • 500 mcg – 2 mg subcutaneously daily or every other day
  • Strong anti-inflammatory profile with CNS penetration; theoretically sound for hypothalamic inflammation but human menopause data is absent
  • BPC-157
  • Tissue repair and angiogenesis; broad anti-inflammatory effects via modulation of growth factor pathways
  • No direct vasomotor symptom studies; reduces systemic inflammation and supports mucosal/vascular healing in animal models
  • 250–500 mcg subcutaneously daily
  • Indirect benefit possible through general inflammation reduction; not specific to thermoregulatory pathways. Use as adjunct only
  • Selank
  • Anxiolytic and immune-modulating; synthetic tuftsin analog; regulates monoamine and cytokine balance
  • Reduces anxiety and HPA-axis hyperactivity in clinical trials; no menopause-specific research
  • 300–600 mcg intranasally or subcutaneously daily
  • Intranasal or subcutaneous
  • May help if hot flashes are exacerbated by anxiety and stress; not a primary vasomotor intervention